Ondansetron (4mg)
Emigo-MD Tablet may be used alone or with other medications and can be taken with or without food. Your doctor will suggest the appropriate dose depending on what you are taking it for. The first dose is normally taken before the start of surgery, chemotherapy, or radiotherapy. After these treatments, take any further doses as prescribed by your doctor (normally only for a few days at most). Take it regularly at the same time(s) each day to get the most benefit. Be careful not to take too much. This medicine does not relieve other side effects associated with cancer treatments. Also, it has little effect on vomiting caused by motion sickness. The most common side effects of taking this medicine include headache, diarrhea, or constipation and feeling tired. These symptoms should disappear when you stop taking the medicine. However, if these side effects bother you or do not go away, your doctor may be able to suggest ways of preventing or reducing them. Before taking this medicine, tell your doctor if you have heart or liver problems or a blockage in your stomach or intestines. Also, tell your doctor about any other medicines you might be taking, especially medicines to treat epilepsy, heart problems, cancer, and depression. These may affect, or be affected by, this medicine. If you are pregnant or breastfeeding, ask for advice from your doctor.
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about themCommon side effects of Emigo
10 tablet dt
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Take this medicine in the dose and duration as advised by your doctor. Dissolve it in a glass of water before taking it. Emigo-MD Tablet may be taken with or without food, but it is better to take it at a fixed time.
Emigo-MD Tablet is an antiemetic medication. It works by blocking the action of a chemical messenger (serotonin) in the brain that may cause nausea and vomiting during anti-cancer treatment (chemotherapy) or after surgery.
Related Warnings
Caution is advised when consuming alcohol with Emigo-MD Tablet. Please consult your doctor.
Information regarding the use of Emigo-MD Tablet during pregnancy is not available. Please consult your doctor.
Information regarding the use of Emigo-MD Tablet during breastfeeding is not available. Please consult your doctor.
It is not known whether Emigo-MD Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Emigo-MD Tablet is safe to use in patients with kidney disease. No dose adjustment of Emigo-MD Tablet is recommended.
However, inform your doctor if you have an underlying kidney disease. Limited information is available in patients taking this medicine for more than one day.
There is limited information available on the use of Emigo-MD Tablet in patients with liver disease. Please consult your doctor.
Emigo-MD Tablet starts working within half an hour to 2 hours. It dissolves rapidly into the bloodstream and starts showing its effect.
The most common side effects of Emigo-MD Tablet are constipation, diarrhea, fatigue and headache. However, these are usually not bothersome and resolve on their own after some time. Consult your doctor if these persist or worry you.
Emigo-MD Tablet should be taken with a full glass of water, with or without food. It should be used exactly as per the dose and duration advised by the doctor. Usually, the first dose of Emigo-MD Tablet is taken before the start of your surgery, chemotherapy or radiation treatment.
No, Emigo-MD Tablet is an antiemetic and not a steroid. Emigo-MD Tablet is a selective 5-HT3 receptor antagonist. It is prescribed for the prevention and treatment of nausea and vomiting which is commonly observed after surgery or due to cancer chemotherapy.
No, Emigo-MD Tablet does not work for seasickness. This is because Emigo-MD Tablet has very little effect on the nausea associated with motion sickness.
